Advertisements

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs.....»»

Category: topSource: business-standardJan 12th, 2018

UK rejects Gilead"s CAR-T cancer cell therapy as too expensive

UK rejects Gilead"s CAR-T cancer cell therapy as too expensive.....»»

Category: global-financeSource: reutersAug 28th, 2018

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India.....»»

Category: featuresSource: business-standardFeb 28th, 2018

Gilead to buy Kite for promising cancer therapies in $12 bln deal

Gilead to buy Kite for promising cancer therapies in $12 bln deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Gilead to buy Kite for promising cancer therapies in $12 billion deal

Gilead to buy Kite for promising cancer therapies in $12 billion deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Roche posts modest Q3 sales beat as new drugs offset hit from copies

Roche posts modest Q3 sales beat as new drugs offset hit from copies.....»»

Category: global-financeSource: reutersOct 17th, 2018

J&J beats profit estimates, lifts outlook on pharma unit strength

J&J beats profit estimates, lifts outlook on pharma unit strength.....»»

Category: global-financeSource: reutersOct 16th, 2018

NITI Aayog, Oracle join hands against counterfeit drugs in India

NITI Aayog, Oracle join hands against counterfeit drugs in India.....»»

Category: infotechSource: sifySep 29th, 2018

Meet S Srinivasan, the activist-entrepreneur who got 329 irrational combination drugs banned - Moneycontrol.com

Meet S Srinivasan, the activist-entrepreneur who got 329 irrational combination drugs banned - Moneycontrol.com.....»»

Category: topSource: googlenewsSep 17th, 2018

Bayer"s pharma unit head Weinand quits to join Sanofi

Bayer"s pharma unit head Weinand quits to join Sanofi.....»»

Category: global-financeSource: reutersSep 13th, 2018

India bans 328 combination drugs in setback for pharma companies

India bans 328 combination drugs in setback for pharma companies.....»»

Category: global-financeSource: reutersSep 13th, 2018

Exclusive: Pharma sector warns Saudis on German drug curbs

Exclusive: Pharma sector warns Saudis on German drug curbs.....»»

Category: global-financeSource: reutersAug 22nd, 2018

FDA announcement leads Sun Pharma to recall 2,500 Bottles Of Diabetes Drugs

FDA announcement leads Sun Pharma to recall 2,500 Bottles Of Diabetes Drugs.....»»

Category: marketsSource: sifyJul 30th, 2018

Johnson & Johnson profit beat fueled by strength in pharma business

Johnson & Johnson profit beat fueled by strength in pharma business.....»»

Category: global-financeSource: reutersJul 17th, 2018

US trade under a cloud, China opens to Indian pharma - Economic Times

US trade under a cloud, China opens to Indian pharma - Economic Times.....»»

Category: topSource: googlenewsJul 15th, 2018

Exclusive: With U.S. trade under a cloud, China opens to Indian pharma

Exclusive: With U.S. trade under a cloud, China opens to Indian pharma.....»»

Category: global-financeSource: reutersJul 12th, 2018

Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod - Business Standard

Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod - Business Standard.....»»

Category: topSource: googlenewsJun 12th, 2018

Pharma shares under pressure;Glenmark hits 52-week low, Sun Pharma falls 6%

Pharma shares under pressure;Glenmark hits 52-week low, Sun Pharma falls 6%.....»»

Category: topSource: business-standardMay 11th, 2018

Hold Glenmark Pharma, advises Sumit Bilgaiyan

Hold Glenmark Pharma, advises Sumit Bilgaiyan.....»»

Category: topSource: moneycontrolApr 9th, 2018

Pharma may see recovery with FY19 profit set to jump 20-22%: Report

Pharma may see recovery with FY19 profit set to jump 20-22%: Report.....»»

Category: economySource: moneycontrolApr 3rd, 2018

Pharma sector may post single-digit growth in FY18-20: Report

Pharma sector may post single-digit growth in FY18-20: Report.....»»

Category: economySource: moneycontrolApr 2nd, 2018